Sarepta Therapeutics, Inc. (SRPT) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Stock Price

$124.88

$1.81

(1.47%)

Day's range

$121.18

$125.25

Consensus Rating

Hold

Based on 28 Analyst Ratings
Consensus Price Target

$169.63

35.83% Upside

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date
10/20/2024	Jefferies	Andrew Tsai	$165.00	$127.08	29.84%
08/08/2024	Evercore ISI	Gavin Clark-Gartner	$179.00	$136.40	31.23%
08/08/2024	Piper Sandler	Biren Amin	$200.00	$140.06	42.8%
08/08/2024	Barclays	Gena Wang	$203.00	$140.06	44.94%
08/08/2024	RBC Capital	Brian Abrahams	$181.00	$140.06	29.23%
07/29/2024	RBC Capital	Brian Abrahams	$182.00	$147.88	23.07%
06/27/2024	BMO Capital	Kostas Biliouris	$200.00	$154.79	29.21%
06/26/2024	Piper Sandler	Biren Amin	$205.00	$156.91	30.65%
06/24/2024	Evercore ISI	Gavin Clark-Gartner	$185.00	$160.72	15.11%
06/24/2024	Mizuho Securities	Uy Ear	$200.00	$165.13	21.12%
06/21/2024	Robert W. Baird	Brian Skorney	$200.00	$171.35	16.72%
06/13/2024	Robert W. Baird	Brian Skorney	$170.00	$124.00	37.1%
06/13/2024	Piper Sandler	Biren Amin	$157.00	$119.98	30.86%
06/13/2024	Barclays	Gena Wang	$185.00	$119.98	54.19%
06/07/2024	BMO Capital	Kostas Biliouris	$170.00	$117.44	44.75%
05/28/2024	RBC Capital	Brian Abrahams	$142.00	$123.46	15.02%
05/20/2024	RBC Capital	Brian Abrahams	$157.00	$130.70	20.12%
05/17/2024	Mizuho Securities	Uy Ear	$179.00	$132.74	34.85%
05/14/2024	Oppenheimer	Hartaj Singh	$180.00	$131.70	36.67%
05/06/2024	Morgan Stanley	Matthew Harrison	$165.00	$135.04	22.19%
05/02/2024	RBC Capital	Brian Abrahams	$141.00	$130.90	7.72%
03/01/2023	Morgan Stanley	Matthew Harrison	$187.00	$145.01	28.96%
11/02/2022	Needham	Gil Blum	$158.00	$105.01	50.46%
03/01/2022	Needham	Gil Blum	$150.00	$79.56	88.54%
03/01/2022	Berenberg Bank	Zhiqiang Shu	$94.00	$79.56	18.15%
01/09/2022	Mizuho Securities	Uy Ear	$160.00	$76.15	110.11%
01/04/2022	BTIG	Yun Zhong	$125.00	$84.09	48.65%
01/03/2022	Oppenheimer	Hartaj Singh	$125.00	$89.16	40.2%
10/14/2021	Credit Suisse	Judah Frommer	$95.00	$84.19	12.84%

Sarepta Therapeutics, Inc. Frequently Asked Questions

What analysts cover Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. has been rated by research analysts at Jefferies, Evercore ISI, Piper Sandler, Barclays, RBC Capital, BMO Capital in the past 90 days.

Get The App

Sarepta Therapeutics, Inc. (SRPT) Analyst Forecast

Consensus Rating

Consensus Price Target

Recent Analyst Forecasts and Stock Ratings

Sarepta Therapeutics, Inc. Frequently Asked Questions

What analysts cover Sarepta Therapeutics, Inc.?

Select an alert type

Setup alert

Premium Content

Log In

Email Verification

Welcome to Stocks.News!

Create Your Account

Email Verification